Cardio Diagnostics Holdings Inc. Revenue 2021–2025
Cardio Diagnostics Holdings Inc. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cardio Diagnostics Holdings Inc. revenue for the quarter ending March 31, 2026 was 2680, a 185.11% increase year-over-year.
- Cardio Diagnostics Holdings Inc. revenue for the twelve months ending March 31, 2026 was 13950, a 65.48% decrease year-over-year.
- Cardio Diagnostics Holdings Inc. annual revenue for 2025 was 14825, a 57.51% decrease from 2024.
- Cardio Diagnostics Holdings Inc. annual revenue for 2024 was 34890, a 104.45% increase from 2023.
- Cardio Diagnostics Holdings Inc. annual revenue for 2023 was 17065, a 1696.32% increase from 2022.
- Cardio Diagnostics Holdings Inc. annual revenue for 2022 was 950.
Cardio Diagnostics Holdings Inc. (CDIO) — Frequently Asked Questions
Cardio Diagnostics Holdings Inc. (CDIO) is a publicly traded US company. It has a market capitalization of $3M. In fiscal 2025 it reported revenue of $14,825 and net income of -$6M. Explore CDIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Cardio Diagnostics Holdings Inc.'s market cap?
Cardio Diagnostics Holdings Inc. (CDIO) has a market capitalization of $3M.
What is the CDIO stock price?
CDIO trades at $1.93 (-0.52% on the day).
How much revenue does Cardio Diagnostics Holdings Inc. make?
Cardio Diagnostics Holdings Inc. reported revenue of $14,825 in fiscal 2025.
Is CDIO profitable?
In fiscal 2025, Cardio Diagnostics Holdings Inc. reported net income of -$6M.